ShiraTronics
Company · Minneapolis, Minnesota, USA
Developing an implanted neurostimulation therapy for chronic migraine.
In the news
Clinical trialsNeuromodulation
ShiraTronics completes enrollment in pivotal trial of an implanted migraine stimulator
RELIEV-CM2 enrolled 300 people with chronic migraine across 28 sites; five new billing codes take effect in 2027.